Heads of working groups

ACC Working Group

Felix Beuschlein, MD
Endocrine Research Unit
Medizinische Klinik und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany

Felix Beuschlein is Professor of Internal Medicine/Endocrinology, Head of the Endocrine Research Unit and runs the Endocrine Outpatient Clinic at the University Hospital in Munich. His main scientific interest pertain to all fields of adrenal research including adrenocortical carcinoma, primary aldosteronism, Cushing’s syndrome and pheochromocytoma. He has served as the chairman of ENSAT between 2008 and 2016 and has led an FP7 funded consortium on adrenal tumors (ENSAT-CANCER).

Mercedes Robledo, PhD
Hereditary Endocrine Cancer, Group Leader
Human Cancer Genetics Programme
Spanish National Cancer Centre (CNIO)
C/ Melchor Fernández Almagro 3
Madrid, Spain

Mercedes Robledo is the head of the Hereditary Endocrine Cancer Group, in the Human Genetics Cancer Program at the Spanish National Cancer Center (CNIO), Madrid, Spain. Her Group is interested in identifying high and low genetic risk factors involved in pheochromocytoma and thyroid cancer susceptibility. To this end, we analyse tumour samples and look for differences between genomic features according to the different individual genetic backgrounds. Such comprehensive characterisation allows us, not only to define diagnostic and prognostic markers associated with primary mutations, but also to pinpoint specific altered pathways that can lead to the identification of future therapeutic targets.

Period in office: 2017-2020

NAPACA Working Group

Wiebke Arlt, MD, DSc., FRCP, FMedSci
Institute of Metabolism and Systems Research (IMSR)
University of Birmingham
& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)
Birmingham Health Partners
Birmingham, UK

Professor Wiebke Arlt is William Withering Chair of Medicine and Director of the Institute of Metabolism and Systems Research at the University of Birmingham, UK. She leads a multi-disciplinary research group focussing on steroid endocrinology in the context of adrenal and gonadal disorders. She is a Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her main interests are adrenal incidentaloma, adrenocortical carcinoma and adrenal steroid excess syndromes.

Period in office: 2017-2020

APA Working Group

Martin Reincke, MD

Medizinische Klinik und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany

Martin Heinrich Reincke is the director of the Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians University in Munich and Chair of the Department of Endocrinology and Diabetology..

His research focus includes adrenal physiology and pathophysiology, endocrine hypertension, pituitary disease, mineralocorticoid and glucocorticoid action and stress research. Professor Reincke is heading a research team specifically exploring the prevalence and relevance of mineralocorticoid excess in resistant hypertension on the epidemiological, clinical, genetic and molecular level.

Professor Reincke is a member of many national and international societies, including the Endocrine Society, European Society of Endocrinology and European Network of the study of adrenal tumors. He has served in the Executive Board of the German Endocrine Society and European Society of Endocrinology, is on the editorial board of several international journals, and has served as teaching dean of the faculty from 2006-2012.

Period in office: 2017-2020

Chairs of local ENSAT scientific meetings committees

Massimo Manelli

17th ENS@T meeting 2018, Florence, Italy.

Prof. Mannelli is Full Professor of Endocrinology in the Department of Experimental and Clinical Biomedical Sciences, University of Florence. He is the Director of the Clinical Endocrine Unit at the Azienda Ospedaliera-Universitaria Careggi, Florence. He has served as Director of the Post-graduate School of Endocrinology, University of Florence. His main research interests are pheochromocytoma/paragangliomas and adrenocortical cancer.He is coordinator of the Pheochromocytoma/Paraganglioma working group of the Italian Endocrine Society.

Period in office: 2017-2018

Björklund Peyman, 18th ENS@T meeting 2019, Uppsala, Sweden. Period in office: 2017-2019

Felix Beuschlein, 19th ENS@T meeting 2020, Munich, Germany. Period in office: 2017-2020

---------------------------------------------------------------------------------------------------------------------------------------------

Felix Beuschlein, Munich, Germany. Period in office: 2009-2016

Former members of the Executive Committee:

Henri Timmers, MD, PhD
 Division of Endocrinology
 Department of Internal Medicine
 Radboud University Medical Centre
 Geert Grooteplein Zuid 8
 Radboud, The Netherlands

Henri Timmers (1971), M.D./Ph.D., is clinical endocrinologist and assistant professor at the Department of Medicine, section of Endocrinology, Radboud University Medical Centre, in Nijmegen, the Netherlands. He is head of the Radboud Adrenal Center and member of the steering committees of ENS@T and the international  Pheochromocytoma and Paraganglioma Research Support Organization (PRESSOR). His principle clinical and scientific focus is on adrenal diseases, especially pheochromocytoma and paraganglioma.

Former Secretary of ENS@T. Period in office: 2011-2017

Jérôme Bertherat, MD, PhD
Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre National de la Recherche Scientifique (CNRS)
Institut Cochin, Université Paris-Descartes
22, rue Mechain
Paris, France

Period in office: 2009-2016

Wiebke Arlt, Birmingham, UK. Period in office: 2009-2016

Massimo Terzolo, MD
Head of Department of Internal Medicine I
University of Torino
Regione Gonzole 10
Torino, Italy

Period in office: 2009-2014